CoChat

Predicting rehospitalization within 2 years of initial patient admission for a major depressive episode: a multimodal machine learning approach

Open access
Cearns, Micah, Opel, Nils, Clark, Scott, Kaehler, Claas, Thalamuthu, Anbupalam, Heindel, Walter, Winter, Theresa, Teismann, Henning, Minnerup, Heike, Dannlowski, Udo, Berger, Klaus, Baune, Bernhard T. · 2019 · Translational Psychiatry
Cited by 43

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Machine learning methods show promise to translate univariate biomarker findings into clinically useful multivariate decision support systems. At current, works in major depressive disorder have predominantly focused on neuroimaging and clinical predictor modalities, with genetic, blood-biomarker, and cardiovascular modalities lacking. In addition, the prediction of rehospitalization after an initial inpatient major depressive episode is yet to be explored, despite its clinical importance. To address this gap in the literature, we have used baseline clinical, structural imaging, blood-biomarker, genetic (polygenic risk scores), bioelectrical impedance and electrocardiography predictors to predict rehospitalization within 2 years of an initial inpatient episode of major depression. Three hundred and eighty patients from the ongoing 12-year Bidirect study were included in the analysis (rehospitalized: yes = 102, no = 278). Inclusion criteria was age ≥35 and <66 years, a current or recent hospitalisation for a major depressive episode and complete structural imaging and genetic data. Optimal performance was achieved with a multimodal panel containing structural imaging, blood-biomarker, clinical, medication type, and sleep quality predictors, attaining a test AUC of 67.74 (p = 9.99−05). This multimodal solution outperformed models based on clinical variables alone, combined biomarkers, and individual data modality prognostication for rehospitalization prediction. This finding points to the potential of predictive models that combine multimodal clinical and biomarker data in the development of clinical decision support systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-019-0615-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Keller, M. B., Lavori, P. W., Lewis, C. E. & Klerman, G. L. Predictors of relapse in major depressive disorder. JAMA 250, 3299–3304 (1983). · DOI · Paper page
  2. Grilo, C. M. et al. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J. Clin. Psychiatry 71, 1629–1635 (2010). · DOI · Paper page
  3. Zobel, A. W., Yassouridis, A., Frieboes, R. M. & Holsboer, F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am. J. Psychiatry 156, 949–951 (1999). · DOI · Paper page
  4. Berman, R. M. et al. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch. Gen. Psychiatry 56, 395–403 (1999). · DOI · Paper page
  5. Gili, M., Vicens, C., Roca, M., Andersen, P. & McMillan, D. Interventions for preventing relapse or recurrence of depression in primary health care settings: a systematic review. Prev. Med. 76, S16–S21 (2015). · DOI
  6. Teismann, H., et al. Establishing the bidirectional relationship between depression and subclinical arteriosclerosis—rationale, design, and characteristics of the BiDirect Study. BMC Psychiatry 14, 3–4. https://doi.org/10.1186/1471-244x-14-174 (2014). · DOI · Paper page
  7. Kambeitz, J. et al. Detecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studies. Biol. Psychiatry 82, 330–338 (2017). · DOI · Paper page
  8. Schmaal, L. et al. Predicting the naturalistic course of major depressive disorder using clinical and multimodal neuroimaging information: a multivariate pattern recognition study. Biol. Psychiatry 78, 278–286 (2015). · DOI · Paper page
  9. Moayedoddin, B. et al. Prevalence and clinical characteristics of the DSM IV major depression among general internal medicine patients. Eur. J. Intern. Med. 24, 763–766 (2013). · DOI
  10. Schweiger, U. et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom. Med. 61, 292–296 (1999). · DOI · Paper page
  11. Lopresti, A. L., Hood, S. D. & Drummond, P. D. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J. Affect. Disord. 148, 12–27 (2013). · DOI · Paper page
  12. Murphy, M. J. & Peterson, M. J. Sleep disturbances in depression. Sleep Med. Clin. 10, 17–23 (2015). · DOI · Paper page
  13. Chekroud, S. R. & Chekroud, A. M. Efficacy of resistance exercise training with depressive symptoms. JAMA Psychiatry 75, 1091–1092 (2018). · DOI
  14. Nierenberg, A. A. et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am. J. Psychiatry 163, 1519–1530 (2006). quiz 665. · DOI · Paper page
  15. Joffe, R. T. & Marriott, M. Thyroid hormone levels and recurrence of major depression. Am. J. Psychiatry 157, 1689–1691 (2000). · DOI · Paper page
  16. Joffe, R., Segal, Z. & Singer, W. Change in thyroid hormone levels following response to cognitive therapy for major depression. Am. J. Psychiatry 153, 411–413 (1996). · DOI · Paper page
  17. Sassarini, D. J. Depression in midlife women. Maturitas 94, 149–154. · DOI · Paper page
  18. Schiller, C. E., Meltzer-Brody, S. & Rubinow, D. R. The role of reproductive hormones in postpartum depression. CNS Spectr. 20, 48–59 (2015). · DOI · Paper page
  19. Rodgers, S. et al. Serum testosterone levels and symptom-based depression subtypes in men. Front. Psychiatry 6, 61 (2015). · DOI
  20. Kische, H. et al. Associations of androgens with depressive symptoms and cognitive status in the general population. PLoS One 12, e0177272 (2017). · DOI · Paper page
  21. Maes, M. et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr. Scand. 95, 212–221 (1997). · DOI · Paper page
  22. Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B (Stat. Methodol.) 67, 301–320 (2005). · DOI · Paper page
  23. Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1 (2010). · DOI · Paper page
  24. Platt, J. Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods. In: Smola, A. J., Barlett, P. L., Scholkopf, B. & Schuurmans, D. (eds.) Advances in Large Margin Classifiers. Vol. 10, 61–74 (The MIT press, Cambridge, Massacheussets, London, England, 1999).
  25. Koutsouleris, N. et al. Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysis. JAMA Psychiatry 75, 1156–1172 (2018). · DOI · Paper page
  26. Koutsouleris, N., Kahn, R. S. & Chekroud, A. M. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach (vol 3, pg 935, 2016). Lancet Psychiatry 4, 95 (2017). · doi:10.1016/s2215-0366(17)30009-3
  27. Amare, A. T. et al. Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA Psychiatry 75, 65–74 (2018).
  28. Amare, A. T. et al. Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder. Front. Psychiatry 9, 65 (2018). · DOI
  29. Zheutlin, A. B. et al. Multivariate pattern analysis of genotype–phenotype relationships in schizophrenia. Schizophrenia Bull. 44, 1045–1052 (2018). · DOI
  30. Bodnar, M. et al. The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study. BJPsych Open. 2, 139–146 (2016). · DOI
  31. Chakos, M. H. et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatry 186, 26–31 (2005). · DOI · Paper page

Cited by

See all 43

Metadata

Authors
Cearns, M., Opel, N., Clark, S., Kaehler, C., Thalamuthu, A., Heindel, W., Winter, T., Teismann, H., Minnerup, H., Dannlowski, U., Berger, K., & Baune, B. T.
Venue
Translational Psychiatry
Published
2019-11-11
Volume
9
Issue
1
Pages
285-285
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2987399022
Cited by
43
References
22
FWCI
3.00
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Deutsche Forschungsgemeinschaft (DA1151/5-1, DA1151/5-2, FOR2107)
  • BMBF - German Federal Ministry of Education and Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.